Yun Yen
2022
In 2022, Yun Yen earned a total compensation of $93.3K as Director at LIXTE BIOTECHNOLOGY HOLDINGS, a 79% decrease compared to previous year.
Compensation breakdown
| Option Awards | $63,340 |
|---|---|
| Other | $30,000 |
| Total | $93,340 |
Yen received $63.3K in option awards, accounting for 68% of the total pay in 2022.
Yen also received $30K in other compensation.
Rankings
In 2022, Yun Yen's compensation ranked 5,608th out of 5,753 executives tracked by ExecPay. In other words, Yen earned more than 2.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,608 out of 5,753 | 3rd |
Division Manufacturing | 3,062 out of 3,133 | 2nd |
Major group Chemicals And Allied Products | 1,390 out of 1,419 | 2nd |
Industry group Drugs | 1,297 out of 1,320 | 2nd |
Industry Pharmaceutical Preparations | 946 out of 966 | 2nd |
Source: SEC filing on November 4, 2024.
Yen's colleagues
We found six more compensation records of executives who worked with Yun Yen at LIXTE BIOTECHNOLOGY HOLDINGS in 2022.
2022
Bas der Baan
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
René Bernards
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Regina Brown
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Stephen Forman
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Philip Palmedo
LIXTE BIOTECHNOLOGY HOLDINGS
Director
2022
Gil Schwartzberg
LIXTE BIOTECHNOLOGY HOLDINGS